PRURITUS
Clinical trials for PRURITUS explained in plain language.
Never miss a new study
Get alerted when new PRURITUS trials appear
Sign up with your email to follow new studies for PRURITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug offers hope for teens with Kidney-Related itching
Symptom relief Recruiting nowThis study tests if a medicine called difelikefalin is safe for teenagers aged 12 to 17 who have severe itching due to kidney disease and are on dialysis. All 18 participants will receive the medicine during their regular dialysis visits for up to 12 weeks. The goal is to see if …
Matched conditions: PRURITUS
Phase: PHASE2 • Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Symptom relief
Last updated May 17, 2026 04:12 UTC
-
Virtual reality offers new hope for burn Survivors' chronic symptoms
Symptom relief Recruiting nowThis study tests whether a relaxation technique called progressive muscle relaxation (PMR) — done with or without virtual reality (VR) — can help adult burn survivors manage ongoing symptoms like pain, itch, anxiety, sleep problems, and fatigue. About 34 participants will try bot…
Matched conditions: PRURITUS
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated May 17, 2026 04:12 UTC
-
Neck stretching may cut itch drug use, small study hopes
Symptom relief Recruiting nowThis pilot study tests whether gentle neck traction can help people with nerve-related itching on the scalp, arms, or upper back use less medication. Twelve adults on stable doses of gabapentin or pregabalin will try home neck traction for 12 weeks. The goal is to see if this sim…
Matched conditions: PRURITUS
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 17, 2026 04:12 UTC
-
New hope for mystery itch: drug trial targets chronic sufferers
Symptom relief Recruiting nowThis study tests a drug called dupilumab for adults with severe, long-term itching that has no known cause. About 284 people aged 18 to 90 will receive either dupilumab or a placebo for 24 weeks, along with standard itch treatments. The goal is to see if dupilumab can safely redu…
Matched conditions: PRURITUS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
Researchers investigate why some liver injuries cause severe itching
Knowledge-focused Recruiting nowThis study looks at how often and how long itching occurs in people with drug-induced liver injury (DILI). Researchers will follow 50 adults with DILI or other liver conditions, using questionnaires to track itching symptoms. The goal is to better understand the problem and prepa…
Matched conditions: PRURITUS
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated May 17, 2026 04:10 UTC